转变哮喘治疗模式。 - Suppr | 超能文献

Shifting the Asthma Treatment Paradigm.

作者信息

Condren Michelle

出版信息

J Pediatr Pharmacol Ther. 2021;26(5):425-426. doi: 10.5863/1551-6776-26.5.425. Epub 2021 Jun 28.

DOI:10.5863/1551-6776-26.5.425

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8244947/

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Shifting the Asthma Treatment Paradigm.转变哮喘治疗模式。

J Pediatr Pharmacol Ther. 2021;26(5):425-426. doi: 10.5863/1551-6776-26.5.425. Epub 2021 Jun 28.

2

Update on the NAEPPCC Asthma Guidelines: The wait is over, or is it?NAEPPCC 哮喘指南更新：漫长的等待，结束了？

J Allergy Clin Immunol. 2020 Dec;146(6):1275-1280. doi: 10.1016/j.jaci.2020.01.025. Epub 2020 Jan 28.

3

Chronic Asthma Treatment: Common Questions and Answers.慢性哮喘治疗：常见问题与解答。

Am Fam Physician. 2023 Apr;107(4):358-368.

4

Asthma guidelines: comparison of the National Heart, Lung, and Blood Institute Expert Panel Report 4 with Global Initiative for Asthma 2021.哮喘指南：美国国立心肺血液研究所专家小组报告4与全球哮喘防治创议2021版的比较

Curr Opin Pulm Med. 2022 May 1;28(3):234-244. doi: 10.1097/MCP.0000000000000867. Epub 2022 Feb 21.

5

2020 Updated Asthma Guidelines: Intermittent inhaled corticosteroids and long-acting muscarinic antagonists for asthma-the latest NAEPP guidelines are SMART!

J Allergy Clin Immunol. 2021 May;147(5):1640-1642. doi: 10.1016/j.jaci.2021.03.012. Epub 2021 Mar 17.

6

Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.基于最新哮喘指南的长效β2肾上腺素能激动剂在哮喘管理中的作用

Curr Opin Pulm Med. 2008 Jan;14(1):57-63. doi: 10.1097/MCP.0b013e3282f27121.

7

Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma.长效毒蕈碱拮抗剂在哮喘管理中的定位

Allergy Asthma Immunol Res. 2017 Sep;9(5):386-393. doi: 10.4168/aair.2017.9.5.386.

8

Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis.吸入性糖皮质激素与长效毒蕈碱拮抗剂对未控制的持续性哮喘患者哮喘控制的影响：一项系统评价和荟萃分析

JAMA. 2018 Apr 10;319(14):1473-1484. doi: 10.1001/jama.2018.2757.

9

Understanding the role of long-acting muscarinic antagonists in asthma treatment.了解长效毒蕈碱拮抗剂在哮喘治疗中的作用。

Ann Allergy Asthma Immunol. 2022 Apr;128(4):352-360. doi: 10.1016/j.anai.2021.12.020. Epub 2022 Jan 21.

10

Usage of long-acting muscarinic antagonists and biologics as add-on therapy for patients in the United States with moderate-to-severe asthma.长效毒蕈碱拮抗剂和生物制剂在美国中重度哮喘患者的附加治疗中的应用。

J Asthma. 2022 Jun;59(6):1237-1247. doi: 10.1080/02770903.2021.1922915. Epub 2021 May 22.

本文引用的文献

1

The Role of Biologics in the Management of Asthma in the Pediatric Patient.生物制剂在儿童哮喘管理中的作用

J Pediatr Pharmacol Ther. 2021;26(5):427-436. doi: 10.5863/1551-6776-26.5.427. Epub 2021 Jun 28.

2

2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group.2020 年哮喘管理指南重点更新：国家哮喘教育和预防计划协调委员会专家小组工作组的报告。

J Allergy Clin Immunol. 2020 Dec;146(6):1217-1270. doi: 10.1016/j.jaci.2020.10.003.